Medi Lifestyle returns for US$6.42M placement weeks after rights issue
What's the deal? Medi LifestyleDealroom has a profile for this one. Try Dealroom → has launched a placement to raise gross proceeds of up to US$6.42M, issuing up to 178,588,000 new shares at US$0.04 each. The Catalist-listed company signed a placement agreement with SAC Capital Private LimitedDealroom has a profile for this one. Try Dealroom →, which is acting as placement agent on a best-endeavours basis.
Why now? The placement, announced on August 16, 2026, comes just weeks after Medi Lifestyle issued 189,051,006 shares on July 6 through a renounceable rights issue. Both raises fall under the general mandate approved at the company's April 30 annual general meeting, so no fresh shareholder approval is required.
The terms: The US$0.04 price marks a discount to the volume-weighted average price of US$0.04 recorded on August 11, the last full trading day before a trading halt. After roughly US$118.3K in fees, net proceeds are estimated at about US$6.3M.
What's the endgame? Medi Lifestyle plans to direct 70% of net proceeds — about US$4.41M — to business development and expansion, including acquisitions, strategic investments, and partnerships. Another 25% goes to working capital, with the remaining 5%, or US$334.4K, repaying loans owed to controlling shareholder Chua Yi Hang.
What could go wrong? If fully placed, the new shares would expand the company's issued capital by nearly a third, from 567,153,018 to 745,741,018 shares. The company warned this will result in "significant dilution" for existing holders.
The signal: A second capital raise within roughly a month points to a company leaning heavily on its share issue mandate to fund growth. The back-to-back rights issue and placement suggest Medi Lifestyle is prioritising cash for expansion over shareholder dilution concerns.
Read more: minichart.com.sg
Image credit: Muffet
